Acinetobacter ursingii sp. nov. and Acinetobacter schindleri sp. nov., isolated from human clinical specimens.
about
Defining bacterial species in the genomic era: insights from the genus AcinetobacterBacteremia caused by Acinetobacter ursingiiIdentification of cultured isolates of clinically important yeast species using fluorescent fragment length analysis of the amplified internally transcribed rRNA spacer 2 region (ITS2).Evaluation of amplified rDNA restriction analysis (ARDRA) for the identification of cultured mycobacteria in a diagnostic laboratory.The genomic diversification of the whole Acinetobacter genus: origins, mechanisms, and consequencesBacterial identification, clinical significance, and antimicrobial susceptibilities of Acinetobacter ursingii and Acinetobacter schindleri, two frequently misidentified opportunistic pathogensCharacterization of unusual bacteria isolated from respiratory secretions of cystic fibrosis patients and description of Inquilinus limosus gen. nov., sp. novBacteremia due to Moraxella atlantae in a cancer patient.Acinetobacter septicus sp. nov. association with a nosocomial outbreak of bacteremia in a neonatal intensive care unit.Species-level identification of isolates of the Acinetobacter calcoaceticus-Acinetobacter baumannii complex by sequence analysis of the 16S-23S rRNA gene spacer region.Acinetobacter soli sp. nov., isolated from forest soil.Do biofilm formation and interactions with human cells explain the clinical success of Acinetobacter baumannii?Identification of Acinetobacter isolates from species belonging to the Acinetobacter calcoaceticus-Acinetobacter baumannii complex with monoclonal antibodies specific for O Antigens of their lipopolysaccharides.Standardization and interlaboratory reproducibility assessment of pulsed-field gel electrophoresis-generated fingerprints of Acinetobacter baumanniiDifferences in Acinetobacter baumannii strains and host innate immune response determine morbidity and mortality in experimental pneumoniaNaturally transformable Acinetobacter sp. strain ADP1 belongs to the newly described species Acinetobacter baylyi.Detection of New Delhi metallo-β-lactamase (encoded by blaNDM-1) in Acinetobacter schindleri during routine surveillanceDiversity of Acinetobacter baumannii in four French military hospitals, as assessed by multiple locus variable number of tandem repeats analysisDiversity and clinical impact of Acinetobacter baumannii colonization and infection at a military medical center.Staring at the cold sun: blue light regulation is distributed within the genus Acinetobacter.Evolution of a pathogen: a comparative genomics analysis identifies a genetic pathway to pathogenesis in AcinetobacterNosocomial bacteremia due to an as yet unclassified acinetobacter genomic species 17-like strainAcinetobacter baumannii: emergence of a successful pathogenInfluence of ACB complex genospecies on clinical outcomes in a U.S. hospital with high rates of multidrug resistance.A retrospective study of the incidence, clinical characteristics, identification, and antimicrobial susceptibility of bacteremic isolates of Acinetobacter ursingii.Severe Community-Acquired Bloodstream Infection with Acinetobacter ursingii in Person who Injects DrugsDiverse responses to UV light exposure in Acinetobacter include the capacity for DNA damage-induced mutagenesis in the opportunistic pathogens Acinetobacter baumannii and Acinetobacter ursingiiEmergence of multidrug-resistant Acinetobacter baumannii producing OXA-23 Carbapenemase in Qatar.First case of Pseudoclavibacter bifida bacteremia in an immunocompromised host with chronic obstructive pulmonary disease (COPD).Endemic and epidemic acinetobacter species in a university hospital: an 8-year survey.Bacteremic infection with Pantoea ananatis.Identification of 50 class D β-lactamases and 65 Acinetobacter-derived cephalosporinases in Acinetobacter spp.The synthetic N-terminal peptide of human lactoferrin, hLF(1-11), is highly effective against experimental infection caused by multidrug-resistant Acinetobacter baumannii.Acinetobacter: a potential reservoir and dispenser for β-lactamases.Molecular characterization of acinetobacter isolates collected in intensive care units of six hospitals in Florence, Italy, during a 3-year surveillance program: a population structure analysisIncidence of Acinetobacter species other than A. baumannii among clinical isolates of Acinetobacter: evidence for emerging species.Bacteremia due to Acinetobacter ursingii in infants: Reports of two cases.A Novel Lactobacilli-Based Teat Disinfectant for Improving Bacterial Communities in the Milks of Cow Teats with Subclinical Mastitis.Draft Genome Sequence of Acinetobacter sp. Strain VT-511 Isolated from the Stomach of a Patient with Gastric CancerLack of evidence for "Acinetobacter septicus" as a species different from Acinetobacter ursingii?
P2860
Q21558549-85C0FB2E-564B-4DA3-9097-FE232CD2427CQ24550977-0F635861-457A-4806-A313-E452056A15E3Q24798513-4912A1E4-1AD6-4334-B4DE-52A85BA4BFACQ24805974-35C59101-27CC-45AA-B93C-70C6D18FF219Q28652539-030719B5-5841-4AFD-8485-2D2727640FFBQ30499245-0AFABDDC-E344-4A03-9B55-9D40BF2D9390Q30695296-B60E95BF-2365-45E1-80BF-D5BCAF01E31CQ31089877-B1E07FF5-F6B1-4396-9A75-07213FDFFC29Q31141383-5C0588F5-8210-4460-B4EC-66E44141158AQ31158215-98530475-7AB9-4FC7-B6C6-F8A2EB39C4A2Q33365016-B7626667-0FDD-425C-9E24-4F65BA133AA6Q33588614-E1DCBB95-FB1B-4905-92D3-6EC648809E0AQ33941452-BA6C1B47-1611-4708-A3B0-82029072C392Q34042171-2AACC4AF-0819-4B3A-88FE-B4E8D5029E06Q34162588-E4B6C654-E9AE-462D-BB48-8104B1781D25Q34316009-99C4ED40-B2F7-4468-B80C-6D30232F5642Q34336969-CE6684B7-3C52-4A6C-B7CB-3A2B7D816F35Q34415986-345C9A07-FFAE-4816-936D-3C9B78AD142DQ34487712-2C3DCC13-0BE1-4D94-8428-CB17F90DC094Q34566089-9DB425BB-E900-4E1D-94B4-415964D1FD67Q34568285-88E97506-43E8-45F8-9F9C-38E55F5FD6A4Q34569042-91C1DC37-FD78-4280-B887-7009665A9546Q34795807-A74B6E9A-02BC-4B6C-BD3E-C27216FE8B6EQ34995782-C85C1E88-BFE8-49CF-B658-BE5ECF4F190BQ35794129-87CD4FFD-BA4D-49A9-8369-6B0CB08EEE19Q35874041-C9FB2E84-F7FC-4B5C-A5F6-09B13D73B356Q35959590-4C07D0C8-73B3-424D-A59B-E2734242FF02Q35982095-695C67A9-8727-463D-A533-6F3E9FE24201Q37026488-93BCF43D-1792-43DF-8EEA-AE4753C24EEAQ37410441-33B40ECC-C578-4C95-8C8A-5A1D1876E70DQ37511269-96D581DC-5F64-4F13-B8B8-07A32D6F6060Q37544621-1601EF1F-BAC2-4A62-8AA5-AE35C9D45E4FQ37624613-818D33E4-4CED-491C-A367-177C6E0598E1Q37946953-1AE0552B-C7D5-4CF6-81A2-A3D646194181Q39900310-077ADA07-61FD-4805-9A2C-F52019265B82Q39900631-205A6D69-8A83-4C9E-B06F-D046B2FBA469Q40635693-82E5BBF8-2FD5-4538-851D-BA4546EAC6BDQ42239536-17C55FF4-F793-434D-AFBD-CEBD09F7B8F7Q42381233-BAFAC003-A0B7-4B37-A65C-4E85F1ADBAB8Q42406658-F805CC81-7790-4C86-AF7E-B968BB2F75E9
P2860
Acinetobacter ursingii sp. nov. and Acinetobacter schindleri sp. nov., isolated from human clinical specimens.
description
2001 nî lūn-bûn
@nan
2001 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Acinetobacter ursingii sp. nov ...... from human clinical specimens.
@ast
Acinetobacter ursingii sp. nov ...... from human clinical specimens.
@en
type
label
Acinetobacter ursingii sp. nov ...... from human clinical specimens.
@ast
Acinetobacter ursingii sp. nov ...... from human clinical specimens.
@en
prefLabel
Acinetobacter ursingii sp. nov ...... from human clinical specimens.
@ast
Acinetobacter ursingii sp. nov ...... from human clinical specimens.
@en
P2093
P1476
Acinetobacter ursingii sp. nov ...... from human clinical specimens.
@en
P2093
De Baere T
Dijkshoorn L
Tjernberg I
van der Reijden TJ
P304
P356
10.1099/00207713-51-5-1891
P407
P577
2001-09-01T00:00:00Z